Skip to main content
. 2018 Sep 18;4(1):148–158. doi: 10.1016/j.ekir.2018.09.005

Figure 4.

Figure 4

Survival analysis. Kaplan-Meier survival analysis was performed on the C4d-positive biopsy without evidence of rejection (C4d+WER) as a whole (a) and additionally only on the ABO-compatible (ABOc) C4d+ WER samples (b). The outcome measure was biopsy-proven antibody-mediated rejection (AbMR). The high-AbMR transcripts group had a significantly worse outcome than the low-AbMR transcripts group.